TreeWAS – Variant ID: rs13174863

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R16.0 Hepatomegaly, not elsewhere classified	0.020	0.980	0.000
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.016	0.984	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.016	0.984	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.016	0.984	0.000
D12.2 Ascending colon	0.015	0.985	0.000
E87.7 Fluid overload	0.015	0.985	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.014	0.986	0.000
R16.1 Splenomegaly, not elsewhere classified	0.013	0.987	0.000
E87.5 Hyperkalaemia	0.012	0.988	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.011	0.989	0.000
E87.4 Mixed disorder of acid-base balance	0.010	0.990	0.000
E87.0 Hyperosmolality and hypernatraemia	0.010	0.990	0.000
L89.1 Stage II decubitus ulcer	0.009	0.991	0.000
E83.5 Disorders of calcium metabolism	0.009	0.991	0.000
L89 Decubitus ulcer	0.009	0.991	0.000
L89.2 Stage III decubitus ulcer	0.009	0.991	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.008	0.991	0.000
E87.6 Hypokalaemia	0.008	0.992	0.000
E87.2 Acidosis	0.008	0.992	0.000
E87.3 Alkalosis	0.008	0.992	0.000
L89.3 Stage IV decubitus ulcer	0.007	0.993	0.000
R11 Nausea and vomiting	0.007	0.993	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.007	0.993	0.000
E83 Disorders of mineral metabolism	0.007	0.993	0.000
E83.4 Disorders of magnesium metabolism	0.006	0.994	0.000
E70-E90 Metabolic disorders	0.006	0.994	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.006	0.994	0.000
I65.2 Occlusion and stenosis of carotid artery	0.000	0.995	0.005
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.995	0.005
E73 Lactose intolerance	0.005	0.995	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.005	0.995	0.000
E83.8 Other disorders of mineral metabolism	0.005	0.995	0.000
E83.2 Disorders of zinc metabolism	0.005	0.995	0.000
E83.0 Disorders of copper metabolism	0.005	0.995	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.005	0.995	0.000
E73.9 Lactose intolerance, unspecified	0.005	0.995	0.000
E83.3 Disorders of phosphorus metabolism	0.005	0.995	0.000
L85.9 Epidermal thickening, unspecified	0.005	0.995	0.000
E79 Disorders of purine and pyrimidine metabolism	0.004	0.995	0.000
E84 Cystic fibrosis	0.004	0.996	0.000
E77 Disorders of glycoprotein metabolism	0.004	0.996	0.000
E76 Disorders of glycosaminoglycan metabolism	0.004	0.996	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.004	0.996	0.000
E72 Other disorders of amino-acid metabolism	0.004	0.996	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.004	0.996	0.000
E70 Disorders of aromatic amino-acid metabolism	0.004	0.996	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.004	0.996	0.000
R74.8 Abnormal levels of other serum enzymes	0.000	0.996	0.004
R69 Unknown and unspecified causes of morbidity	0.004	0.996	0.000
L85 Other epidermal thickening	0.004	0.996	0.000
L85.8 Other specified epidermal thickening	0.004	0.996	0.000
D69.6 Thrombocytopenia, unspecified	0.004	0.996	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.004	0.996	0.000
E73.8 Other lactose intolerance	0.004	0.996	0.000
E73.1 Secondary lactase deficiency	0.004	0.996	0.000
E73.0 Congenital lactase deficiency	0.004	0.996	0.000
R52.1 Chronic intractable pain	0.004	0.996	0.000
F19.1 Harmful use	0.004	0.996	0.000
E85 Amyloidosis	0.004	0.996	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.004	0.996	0.000
D05.1 Intraductal carcinoma in situ	0.004	0.996	0.000
D69 Purpura and other haemorrhagic conditions	0.004	0.996	0.000
E89.0 Postprocedural hypothyroidism	0.004	0.996	0.000
E74 Other disorders of carbohydrate metabolism	0.004	0.996	0.000
E89.4 Postprocedural ovarian failure	0.004	0.996	0.000
E86 Volume depletion	0.004	0.996	0.000
E89.2 Postprocedural hypoparathyroidism	0.004	0.996	0.000
E88 Other metabolic disorders	0.004	0.996	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.004	0.996	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.004	0.996	0.000
E89.5 Postprocedural testicular hypofunction	0.004	0.996	0.000
E89.1 Postprocedural hypoinsulinaemia	0.004	0.996	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.003	0.996	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.000	0.996	0.004
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.003	0.996	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.003	0.996	0.000
E79.1 Lesch-Nyhan syndrome	0.003	0.996	0.000
E89.3 Postprocedural hypopituitarism	0.003	0.997	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.003	0.997	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.003	0.997	0.000
E70.3 Albinism	0.003	0.997	0.000
E70.2 Disorders of tyrosine metabolism	0.003	0.997	0.000
E70.1 Other hyperphenylalaninaemias	0.003	0.997	0.000
E70.0 Classical phenylketonuria	0.003	0.997	0.000
E71.3 Disorders of fatty-acid metabolism	0.003	0.997	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.003	0.997	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.003	0.997	0.000
E71.0 Maple-syrup-urine disease	0.003	0.997	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.003	0.997	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.003	0.997	0.000
E72.5 Disorders of glycine metabolism	0.003	0.997	0.000
E72.4 Disorders of ornithine metabolism	0.003	0.997	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.003	0.997	0.000
E72.2 Disorders of urea cycle metabolism	0.003	0.997	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.003	0.997	0.000
E72.0 Disorders of amino-acid transport	0.003	0.997	0.000
E75.6 Lipid storage disorder, unspecified	0.003	0.997	0.000
E75.5 Other lipid storage disorders	0.003	0.997	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.003	0.997	0.000
E75.3 Sphingolipidosis, unspecified	0.003	0.997	0.000
E75.2 Other sphingolipidosis	0.003	0.997	0.000
E75.1 Other gangliosidosis	0.003	0.997	0.000
E75.0 GM2 gangliosidosis	0.003	0.997	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.003	0.997	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.003	0.997	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.003	0.997	0.000
E76.2 Other mucopolysaccharidoses	0.003	0.997	0.000
E76.1 Mucopolysaccharidosis, type II	0.003	0.997	0.000
E76.0 Mucopolysaccharidosis, type I	0.003	0.997	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.003	0.997	0.000
E77.8 Other disorders of glycoprotein metabolism	0.003	0.997	0.000
E77.1 Defects in glycoprotein degradation	0.003	0.997	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.003	0.997	0.000
E84.9 Cystic fibrosis, unspecified	0.003	0.997	0.000
E84.8 Cystic fibrosis with other manifestations	0.003	0.997	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.003	0.997	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.003	0.997	0.000
H73.8 Other specified disorders of tympanic membrane	0.003	0.997	0.000
I27.0 Primary pulmonary hypertension	0.003	0.997	0.000
S99.9 Unspecified injury of ankle and foot	0.003	0.997	0.000
L85.3 Xerosis cutis	0.003	0.997	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.003	0.997	0.000
L85.0 Acquired ichthyosis	0.003	0.997	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.003	0.997	0.000
M79.79 Fibromyalgia (Site unspecified)	0.003	0.997	0.000
I27 Other pulmonary heart diseases	0.003	0.997	0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.003	0.997	0.000
D69.5 Secondary thrombocytopenia	0.003	0.997	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.000	0.997	0.003
H71 Cholesteatoma of middle ear	0.003	0.997	0.000
I27.2 Other secondary pulmonary hypertension	0.003	0.997	0.000
R47.0 Dysphasia and aphasia	0.003	0.997	0.000
I27.8 Other specified pulmonary heart diseases	0.003	0.997	0.000
D69.2 Other nonthrombocytopenic purpura	0.003	0.997	0.000
E85.9 Amyloidosis, unspecified	0.003	0.997	0.000
E85.8 Other amyloidosis	0.003	0.997	0.000
E85.3 Secondary systemic amyloidosis	0.003	0.997	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.003	0.997	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.003	0.997	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.003	0.997	0.000
H81.2 Vestibular neuronitis	0.003	0.997	0.000
I67.1 Cerebral aneurysm, nonruptured	0.000	0.997	0.003
D69.8 Other specified haemorrhagic conditions	0.003	0.997	0.000
D69.1 Qualitative platelet defects	0.003	0.997	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.003	0.997	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.003	0.997	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.003	0.997	0.000
E74.2 Disorders of galactose metabolism	0.003	0.997	0.000
E74.1 Disorders of fructose metabolism	0.003	0.997	0.000
E74.0 Glycogen storage disease	0.003	0.997	0.000
E88.9 Metabolic disorder, unspecified	0.003	0.997	0.000
E88.8 Other specified metabolic disorders	0.003	0.997	0.000
E88.3 Tumour lysis syndrome	0.003	0.997	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.003	0.997	0.000
F19.2 Dependence syndrome	0.003	0.997	0.000
M85.00 Fibrous dysplasia (monostotic) (Multiple sites)	0.003	0.997	0.000
I27.9 Pulmonary heart disease, unspecified	0.003	0.997	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.003	0.997	0.000
D69.9 Haemorrhagic condition, unspecified	0.003	0.997	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.000	0.997	0.003
I65.8 Occlusion and stenosis of other precerebral artery	0.000	0.997	0.003
H81.0 Meniere's disease	0.003	0.997	0.000
D69.4 Other primary thrombocytopenia	0.003	0.997	0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.000	0.997	0.003
I69.3 Sequelae of cerebral infarction	0.000	0.997	0.003
I67 Other cerebrovascular diseases	0.000	0.997	0.003
E27.1 Primary adrenocortical insufficiency	0.003	0.997	0.000
E88.2 Lipomatosis, not elsewhere classified	0.003	0.997	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.003	0.997	0.000
E80.2 Other porphyria	0.002	0.997	0.000
M16.1 Other primary coxarthrosis	0.003	0.997	0.000
H73 Other disorders of tympanic membrane	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.003	0.997	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.002	0.997	0.000
E80.6 Other disorders of bilirubin metabolism	0.002	0.997	0.000
E80.5 Crigler-Najjar syndrome	0.002	0.997	0.000
E80.3 Defects of catalase and peroxydase	0.002	0.997	0.000
E80.1 Porphyria cutanea tarda	0.002	0.997	0.000
E80.0 Hereditary erythropoietic porphyria	0.002	0.997	0.000
L57.0 Actinic keratosis	0.003	0.997	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.997	0.003
E27 Other disorders of adrenal gland	0.003	0.997	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.997	0.003
G55.2 Nerve root and plexus compressions in spondylosis	0.003	0.997	0.000
L80-L99 Other disorders of the skin and subcutaneous tissue	0.003	0.997	0.000
E27.9 Disorder of adrenal gland, unspecified	0.003	0.997	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.997	0.003
I67.2 Cerebral atherosclerosis	0.000	0.997	0.003
S20.3 Other superficial injuries of front wall of thorax	0.003	0.997	0.000
D69.0 Allergic purpura	0.002	0.997	0.000
I27.1 Kyphoscoliotic heart disease	0.002	0.997	0.000
S27.1 Traumatic haemothorax	0.003	0.997	0.000
S20 Superficial injury of thorax	0.003	0.997	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
M70.46 Prepatellar bursitis-Lower Leg	0.000	0.997	0.003
I65.1 Occlusion and stenosis of basilar artery	0.000	0.997	0.002
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.998	0.002
E85.4 Organ-limited amyloidosis	0.002	0.998	0.000
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
I61 Intracerebral haemorrhage	0.000	0.998	0.002
L98.4 Chronic ulcer of skin, not elsewhere classified	0.002	0.998	0.000
H81 Disorders of vestibular function	0.002	0.998	0.000
S20.0 Contusion of breast	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
I67.8 Other specified cerebrovascular diseases	0.000	0.998	0.002
L82 Seborrhoeic keratosis	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.002	0.998	0.000
F19.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F19.8 Other mental and behavioural disorders	0.002	0.998	0.000
F19.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F19.6 Amnesic syndrome	0.002	0.998	0.000
F19.5 Psychotic disorder	0.002	0.998	0.000
F19.4 Withdrawal state with delirium	0.002	0.998	0.000
F19.3 Withdrawal state	0.002	0.998	0.000
F19.0 Acute intoxication	0.002	0.998	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.998	0.002
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.000	0.998	0.002
I67.5 Moyamoya disease	0.000	0.998	0.002
I67.4 Hypertensive encephalopathy	0.000	0.998	0.002
I67.3 Progressive vascular leukoencephalopathy	0.000	0.998	0.002
I60-I69 Cerebrovascular diseases	0.000	0.998	0.002
I67.0 Dissection of cerebral arteries, nonruptured	0.000	0.998	0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.998	0.002
H72.8 Other perforations of tympanic membrane	0.002	0.998	0.000
N42.1 Congestion and haemorrhage of prostate	0.002	0.998	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.998	0.002
N48.4 Impotence of organic origin	0.002	0.998	0.000
T18.1 Foreign body in oesophagus	0.000	0.998	0.002
L84 Corns and callosities	0.002	0.998	0.000
E27.2 Addisonian crisis	0.002	0.998	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.998	0.002
H65-H75 Diseases of middle ear and mastoid	0.002	0.998	0.000
H73.1 Chronic myringitis	0.002	0.998	0.000
H73.0 Acute myringitis	0.002	0.998	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.998	0.002
D89.3 Immune reconstitution syndrome	0.000	0.998	0.002
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.998	0.002
E27.5 Adrenomedullary hyperfunction	0.002	0.998	0.000
E27.0 Other adrenocortical overactivity	0.002	0.998	0.000
M85.0 Fibrous dysplasia (monostotic)	0.002	0.998	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.002	0.998	0.000
C50.3 Lower-inner quadrant of breast	0.002	0.998	0.000
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.002	0.998	0.000
L87 Transepidermal elimination disorders	0.002	0.998	0.000
L88 Pyoderma gangrenosum	0.002	0.998	0.000
L86 Keratoderma in diseases classified elsewhere	0.002	0.998	0.000
K51.9 Ulcerative colitis, unspecified	0.002	0.998	0.000
L91.9 Hypertrophic disorder of skin, unspecified	0.002	0.998	0.000
L91 Hypertrophic disorders of skin	0.002	0.998	0.000
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.002	0.998	0.000
S20.7 Multiple superficial injuries of thorax	0.002	0.998	0.000
S20.4 Other superficial injuries of back wall of thorax	0.002	0.998	0.000
S27 Injury of other and unspecified intrathoracic organs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.998	0.002
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.998	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.998	0.002
S20.1 Other and unspecified superficial injuries of breast	0.002	0.998	0.000
L83 Acanthosis nigricans	0.002	0.998	0.000
L95 Vasculitis limited to skin, not elsewhere classified	0.002	0.998	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.002	0.998	0.000
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.002	0.998	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
L80 Vitiligo	0.002	0.998	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.998	0.002
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.998	0.002
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.998	0.002
T79.7 Traumatic subcutaneous emphysema	0.002	0.998	0.000
H81.9 Disorder of vestibular function, unspecified	0.002	0.998	0.000
H81.4 Vertigo of central origin	0.002	0.998	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
H81.3 Other peripheral vertigo	0.002	0.998	0.000
S27.2 Traumatic heamopneumothorax	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
H81.8 Other disorders of vestibular function	0.002	0.998	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.998	0.002
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
H72 Perforation of tympanic membrane	0.002	0.998	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
H72.1 Attic perforation of tympanic membrane	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.002	0.998	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
D89.1 Cryoglobulinaemia	0.000	0.998	0.002
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.998	0.002
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.000	0.998	0.002
D05 Carcinoma in situ of breast	0.002	0.998	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.002	0.998	0.000
L93 Lupus erythematosus	0.002	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
T39.0 Salicylates	0.002	0.998	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.002	0.998	0.000
H68 Eustachian salpingitis and obstruction	0.002	0.998	0.000
H67 Otitis media in diseases classified elsewhere	0.002	0.998	0.000
M85.09 Fibrous dysplasia (monostotic) (Site unspecified)	0.002	0.998	0.000
M85.08 Fibrous dysplasia (monostotic) (Other)	0.002	0.998	0.000
M85.07 Fibrous dysplasia (monostotic) (Ankle and foot)	0.002	0.998	0.000
M85.06 Fibrous dysplasia (monostotic) (Lower leg)	0.002	0.998	0.000
M85.05 Fibrous dysplasia (monostotic) (Pelvic region and thigh)	0.002	0.998	0.000
M85.04 Fibrous dysplasia (monostotic) (Hand)	0.002	0.998	0.000
M85.03 Fibrous dysplasia (monostotic) (Forearm)	0.002	0.998	0.000
M85.02 Fibrous dysplasia (monostotic) (Upper arm)	0.002	0.998	0.000
M85.01 Fibrous dysplasia (monostotic) (Shoulder region)	0.002	0.998	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
E21.4 Other specified disorders of parathyroid gland	0.002	0.998	0.000
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
S20.2 Contusion of thorax	0.002	0.998	0.000
H65 Nonsuppurative otitis media	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
L87.9 Transepidermal elimination disorder, unspecified	0.002	0.998	0.000
L87.8 Other transepidermal elimination disorders	0.002	0.998	0.000
L87.2 Elastosis perforans serpiginosa	0.002	0.998	0.000
L87.1 Reactive perforating collagenosis	0.002	0.998	0.000
L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]	0.002	0.998	0.000
L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.002	0.998	0.000
L99.0 Amyloidosis of skin	0.002	0.998	0.000
R68.8 Other specified general symptoms and signs	0.002	0.998	0.000
H70 Mastoiditis and related conditions	0.002	0.998	0.000
S20-S29 Injuries to the thorax	0.002	0.998	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
S27.9 Injury of unspecified intrathoracic organ	0.002	0.998	0.000
S27.8 Injury of other specified intrathoracic organs	0.002	0.998	0.000
S27.7 Multiple injuries of intrathoracic organs	0.002	0.998	0.000
S27.6 Injury of pleura	0.002	0.998	0.000
S27.5 Injury of thoracic trachea	0.002	0.998	0.000
S27.4 Injury of bronchus	0.002	0.998	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.002	0.998	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
S27.3 Other injuries of lung	0.002	0.998	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.002	0.998	0.000
H74 Other disorders of middle ear and mastoid	0.002	0.998	0.000
L94 Other localised connective tissue disorders	0.002	0.998	0.000
L95.1 Erythema elevatum diutinum	0.002	0.998	0.000
L95.0 Livedoid vasculitis	0.002	0.998	0.000
D86 Sarcoidosis	0.000	0.998	0.002
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.002	0.998	0.000
S99 Other and unspecified injuries of ankle and foot	0.002	0.998	0.000
L95.8 Other vasculitis limited to skin	0.002	0.998	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.000	0.998	0.002
S21 Open wound of thorax	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
I61.8 Other intracerebral haemorrhage	0.000	0.998	0.002
S22.40 Multiple fractures of ribs (closed)	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.998	0.002
L98.5 Mucinosis of skin	0.002	0.998	0.000
S21.1 Open wound of front wall of thorax	0.002	0.998	0.000
N19 Unspecified renal failure	0.002	0.998	0.000
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
H69 Other disorders of Eustachian tube	0.001	0.998	0.001
E20-E35 Disorders of other endocrine glands	0.002	0.998	0.000
L60.3 Nail dystrophy	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.000	0.998	0.001
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.000	0.998	0.001
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
I68.0 Cerebral amyloid angiopathy	0.000	0.998	0.001
L71.9 Rosacea, unspecified	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.001	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
T44.0 Anticholinesterase agents	0.001	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
T47.7 Emetics	0.001	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.001	0.998	0.000
T47.5 Digestants	0.001	0.998	0.000
T47.4 Other laxatives	0.001	0.998	0.000
T47.3 Saline and osmotic laxatives	0.001	0.998	0.000
T47.2 Stimulant laxatives	0.001	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.001	0.998	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.002	0.998	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.002	0.998	0.000
I66.8 Occlusion and stenosis of other cerebral artery	0.000	0.998	0.001
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.000	0.998	0.001
I66.3 Occlusion and stenosis of cerebellar arteries	0.000	0.998	0.001
I66.2 Occlusion and stenosis of posterior cerebral artery	0.000	0.998	0.001
I66.1 Occlusion and stenosis of anterior cerebral artery	0.000	0.998	0.001
I66.0 Occlusion and stenosis of middle cerebral artery	0.000	0.998	0.001
L95.9 Vasculitis limited to skin, unspecified	0.001	0.998	0.000
N48.8 Other specified disorders of penis	0.002	0.998	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.000	0.998	0.002
R74 Abnormal serum enzyme levels	0.000	0.998	0.002
E22.1 Hyperprolactinaemia	0.002	0.998	0.000
H72.2 Other marginal perforations of tympanic membrane	0.002	0.998	0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.000	0.998	0.001
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.001	0.998	0.000
L57.5 Actinic granuloma	0.001	0.998	0.000
L57.3 Poikiloderma of Civatte	0.001	0.998	0.000
L57.2 Cutis rhomboidalis nuchae	0.001	0.998	0.000
L57.1 Actinic reticuloid	0.001	0.998	0.000
L93.2 Other local lupus erythematosus	0.001	0.998	0.000
L93.1 Subacute cutaneous lupus erythematosus	0.001	0.998	0.000
E25 Adrenogenital disorders	0.002	0.998	0.000
M06.34 Rheumatoid nodule (Hand)	0.000	0.998	0.002
M54.36 Sciatica (Lumbar region)	0.002	0.998	0.000
S22.50 Flail chest (closed)	0.002	0.998	0.000
H65.0 Acute serous otitis media	0.002	0.998	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.001	0.998	0.000
H67.1 Otitis media in viral diseases classified elsewhere	0.001	0.998	0.000
H67.0 Otitis media in bacterial diseases classified elsewhere	0.001	0.998	0.000
H68.1 Obstruction of Eustachian tube	0.001	0.998	0.000
H68.0 Eustachian salpingitis	0.001	0.998	0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.001	0.998	0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
L91.0 Keloid scar	0.002	0.998	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.000	0.998	0.002
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.001	0.998	0.000
H65.3 Chronic mucoid otitis media	0.002	0.998	0.000
H65.1 Other acute nonsuppurative otitis media	0.001	0.998	0.000
H66.3 Other chronic suppurative otitis media	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.001	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.001	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.001	0.998	0.000
D86.0 Sarcoidosis of lung	0.000	0.998	0.002
H65.4 Other chronic nonsuppurative otitis media	0.002	0.998	0.000
H70.8 Other mastoiditis and related conditions	0.001	0.998	0.000
H70.2 Petrositis	0.001	0.998	0.000
H70.1 Chronic mastoiditis	0.001	0.998	0.000
H70.0 Acute mastoiditis	0.001	0.998	0.000
H74.9 Disorder of middle ear and mastoid, unspecified	0.001	0.998	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.002	0.998	0.000
K22.5 Diverticulum of oesophagus, acquired	0.000	0.998	0.002
S22.4 Multiple fractures of ribs	0.002	0.998	0.000
M85 Other disorders of bone density and structure	0.002	0.998	0.000
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.001	0.998	0.000
S26 Injury of heart	0.001	0.998	0.000
S25 Injury of blood vessels of thorax	0.001	0.998	0.000
S24 Injury of nerves and spinal cord at thorax level	0.001	0.998	0.000
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.001	0.998	0.000
S27.31 Other injuries of lung (with open wound into thoracic cavity)	0.001	0.998	0.000
S27.41 Injury of bronchus (with open wound into thoracic cavity)	0.001	0.998	0.000
S27.40 Injury of bronchus (without open wound into thoracic cavity)	0.001	0.998	0.000
S27.51 Injury of thoracic trachea (with open wound into thoracic cavity)	0.001	0.998	0.000
S27.50 Injury of thoracic trachea (without open wound into thoracic cavity)	0.001	0.998	0.000
S27.61 Injury of pleura (with open wound into thoracic cavity)	0.001	0.998	0.000
S27.60 Injury of pleura (without open wound into thoracic cavity)	0.001	0.998	0.000
S27.71 Multiple injuries of intrathoracic organs (with open wound into thoracic cavity)	0.001	0.998	0.000
S27.70 Multiple injuries of intrathoracic organs (without open wound into thoracic cavity)	0.001	0.998	0.000
S27.81 Injury of other specified intrathoracic organs (with open wound into thoracic cavity)	0.001	0.998	0.000
S27.80 Injury of other specified intrathoracic organs (without open wound into thoracic cavity)	0.001	0.998	0.000
S27.91 Injury of unspecified intrathoracic organ (with open wound into thoracic cavity)	0.001	0.998	0.000
S27.90 Injury of unspecified intrathoracic organ (without open wound into thoracic cavity)	0.001	0.998	0.000
H35.3 Degeneration of macula and posterior pole	0.002	0.998	0.000
H69.8 Other specified disorders of Eustachian tube	0.000	0.998	0.001
L57.4 Cutis laxa senilis	0.001	0.998	0.000
M19.1 Posttraumatic arthrosis of other joints	0.002	0.998	0.000
N48.2 Other inflammatory disorders of penis	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.998	0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)	0.001	0.998	0.000
D86.3 Sarcoidosis of skin	0.000	0.998	0.001
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.998	0.001
L94.9 Localised connective tissue disorder, unspecified	0.001	0.998	0.000
L94.8 Other specified localised connective tissue disorders	0.001	0.998	0.000
L94.6 Ainhum	0.001	0.998	0.000
L94.5 Poikiloderma vasculare atrophicans	0.001	0.998	0.000
L94.4 Gottron's papules	0.001	0.998	0.000
L94.3 Sclerodactyly	0.001	0.998	0.000
L94.1 Linear scleroderma	0.001	0.998	0.000
S82.10 Fracture of upper end of tibia (closed)	0.002	0.998	0.000
E07.8 Other specified disorders of thyroid	0.001	0.998	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.001	0.998	0.000
H69.9 Eustachian tube disorder, unspecified	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations